BDX vs WST — Key Metrics
| Metric | BDX (BECTON DICKINSON & CO) | WST (WEST PHARMACEUTICAL SERVICES INC) |
|---|---|---|
| Price | 179.0 | 370.76 |
| Market Cap | 48.76 Billion | 26.09 Billion |
| P/E (TTM) | 53.92 | 47.11 |
| P/B (Quarterly) | 1.975 | 8.366 |
| P/S (TTM) | 2.34 | 7.84 |
| Net Profit Margin (TTM) | 4.5 | 17.0 |
| Gross Margin (TTM) | 46.4 | 36.8 |
| ROE (TTM) | 3.8 | 18.5 |
| Revenue Growth YoY (TTM) | None | None |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
BDX · BECTON DICKINSON & CO
Underperform
WST · WEST PHARMACEUTICAL SERVICES INC
Greatly Underperform
Recommendation Summary
Stock BDX is projected to underperform the market, stock WST is projected to greatly underperform the market. Upfront Recommendation: BDX.
Financial Metrics
Prices delayed ~15 min
| BDX | Metrics | WST |
|---|---|---|
| $179.00 | Price | $370.76 |
| — | Market Capitalization | — |
| 53.92 | Price to Earnings Ratio | 47.11 |
| 2.34 | Price to Sales | 7.84 |
| 19.26 | Price to FCF Ratio | 59.72 |
| 5.04 | Price to Gross Profit | 21.32 |
| 42.96 | Price to R&D | 350.71 |
| 5.99 | Price to Current Assets | 14.44 |